miRNAs and Their Gene Targets—A Clue to Differentiate Pregnancies with Small for Gestational Age Newborns, Intrauterine Growth Restriction, and Preeclampsia
Authors:
- Angelika V. TimofeevaATAngelika V. Timofeeva
- Ivan S. FedorovIFIvan S. Fedorov
- Alexander G. BrzhozovskiyABAlexander G. Brzhozovskiy
- Anna E. BugrovaABAnna E. Bugrova
- Vitaliy V. ChagovetsVCVitaliy V. Chagovets
- Maria V. VolochaevaMVMaria V. Volochaeva
- Natalia L. StarodubtsevaNSNatalia L. Starodubtseva
- Vladimir E. FrankevichVladimir E. Frankevich
- Evgeny N. NikolaevEvgeny N. Nikolaev
- Roman G. ShmakovRSRoman G. Shmakov
- Gennady T. SukhikhGSGennady T. Sukhikh
Open Access
- 20 April 2021
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 11 (4) , 729
Abstract
Despite the differences in the clinical manifestations of major obstetric syndromes, such as preeclampsia (PE) and intrauterine growth restriction (IUGR), their pathogenesis is based on the dysregulation of proliferation, differentiation, and invasion of cytotrophoblast cells that occur in the developing placenta, decidual endometrium, and myometrial parts of the spiral arteries. To understand the similarities and differences in the molecular mechanisms of PE and IUGR, samples of the placental bed and placental tissue were analyzed using protein mass spectrometry and the deep sequencing of small RNAs, followed by validation of the data obtained by quantitative RT-PCR in real time. A comparison of the transcriptome and proteomic profiles in the samples made it possible to conclude that the main changes in the molecular profile in IUGR occur in the placental bed, in contrast to PE, in which the majority of molecular changes occurs in the placenta. In placental bed samples, significant changes in the ratio of miRNA and its potential target gene expression levels were revealed, which were unique for IUGR (miR-30c-5p/VIM, miR-28-3p/VIM, miR-1-3p/ANXA2, miR-30c-5p/FBN1; miR-15b-5p/MYL6), unique for PE (miR-185-3p/FLNA), common for IUGR and PE (miR-30c-5p/YWHAZ and miR-654-3p/FGA), but all associated with abnormality in the hemostatic and vascular systems as well as with an inflammatory process at the fetal‒maternal interface.Keywords
Funding Information
- State assignment of the Ministry of Healthcare of the Russian Federation (AAAA-A18-118053190026-6)
This publication has 82 references indexed in Scilit:
- Placental Dysfunction and Fetal Programming: The Importance of Placental Size, Shape, Histopathology, and Molecular CompositionSeminars in Reproductive Medicine, 2011
- The “Great Obstetrical Syndromes” are associated with disorders of deep placentationAmerican Journal of Obstetrics and Gynecology, 2011
- Regulation of vimentin intermediate filaments in endothelial cells by hypoxiaAmerican Journal of Physiology-Cell Physiology, 2010
- Review: Reactive oxygen and nitrogen species and functional adaptation of the placentaPlacenta, 2010
- Rheological and Physiological Consequences of Conversion of the Maternal Spiral Arteries for Uteroplacental Blood Flow during Human PregnancyPlacenta, 2009
- Ultrafast and memory-efficient alignment of short DNA sequences to the human genomeGenome Biology, 2009
- Nuclear versus Cytoplasmic Localization of Filamin A in Prostate Cancer: Immunohistochemical Correlation with MetastasesClinical Cancer Research, 2009
- Placental Origins of PreeclampsiaHypertension, 2008
- Identification and expression analysis of genes associated with bovine blastocyst formationBMC Developmental Biology, 2007
- Novel functions of vimentin in cell adhesion, migration, and signalingExperimental Cell Research, 2007